Expression of prostaglandin E receptor subtype EP4 in conjunctival epithelium of patients with ocular surface disorders: Case-control study

BMJ Open

Volumn 2, Issue 5, 2012, Pages

  Ueta, Mayumi ^a,b   Sotozono, Chie ^a   Yamada, Keiko ^a   Yokoi, Norihiko ^a   Inatomi, Tsutomu ^a   Kinoshita, Shigeru ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b DOSHISHA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROSTAGLANDIN E RECEPTOR 4;

ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONJUNCTIVA; CONJUNCTIVA EPITHELIUM; CONJUNCTIVOCHALASIS; CONTROLLED STUDY; CORNEA RODENT ULCER; DISEASE SEVERITY; EYE BURN; EYE INFLAMMATION; EYE SURGERY; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; IMMUNOREACTIVITY; OCULAR CICATRICIAL PEMPHIGOID; OCULAR SURFACE DISEASE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEVENS JOHNSON SYNDROME; TISSUE SECTION; TOXIC EPIDERMAL NECROLYSIS;

EID: 84869756763     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2012-001330     Document Type: Article

References (9)

1. Matsuoka T, Narumiya S. Prostaglandin receptor signaling in disease. ScientificWorldJournal 2007;7:1329-47.
2. Takayama K, Garcia-Cardena G, Sukhova GK, et al. Prostaglandin E2 suppresses chemokine production in human macrophages through the EP4 receptor. J Biol Chem 2002;277:44147-54.
3. Xu XJ, Reichner JS, Mastrofrancesco B, et al. Prostaglandin E2 suppresses lipopolysaccharide-stimulated IFN-beta production. J Immunol 2008;180:2125-31.
4. Shiraishi H, Yoshida H, Saeki K, et al. Prostaglandin E2 is a major soluble factor produced by stromal cells for preventing inflammatory cytokine production from dendritic cells. Int Immunol 2008;20:1219-29.
5. Ueta M, Matsuoka T, Yokoi N, et al. Prostaglandin E2 suppresses polyinosine-polycytidylic acid ( polyI:C)-stimulated cytokine production via prostaglandin E2 receptor (EP) 2 and 3 in human conjunctival epithelial cells. Br J Ophthalmol 2011;95:859-63.
6. Morimoto K, Sugimoto Y, Katsuyama M, et al. Cellular localization of mRNAs for prostaglandin E receptor subtypes in mouse gastrointestinal tract. Am J Physiol 1997;272:G681-7.
7. Kabashima K, Saji T, Murata T, et al. The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut. J Clin Invest 2002;109:883-93.
8. Ueta M, Sotozono C, Yokoi N, et al. Prostaglandin E receptor 4 expression in human conjunctival epithelium and its downregulation in devastating ocular surface inflammatory disorders. Arch Ophthalmol 2010;128:1369-71.
9. Yao C, Sakata D, Esaki Y, et al. Prostaglandin E2-EP4 signaling promotes immune inflammation through Th1 cell differentiation and Th17 cell expansion. Nat Med 2009;15:633-40.